GlassScriptPhysician profile
Dov C Bloch
NPI 1053316414
$7,013.47
in general payments reported to CMS, 2019-2025
17 companies · $2,736 in 2025
The $2,736 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,325 · 2020: $17.21 · 2021: $225 · 2022: $1,349 · 2023: $32.95 · 2024: $328 · 2025: $2,736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,770 · Food and Beverage: $1,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,770.16 |
| Food and Beverage | $1,326.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,680.69 | 2019-2022 | |
| Aerin Medical INC. | $2,536.90 | 2024-2025 | |
| Inspire Medical Systems, INC. | $833.85 | 2022 | |
| Glaxosmithkline, LLC. | $251.03 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $142.60 | 2022-2025 | Libtayo |
| Checkpoint Surgical, INC | $102.75 | 2021-2022 | |
| Integra Lifesciences Corporation | $75.01 | 2022 | |
| Optinose US, INC. | $67.98 | 2025 | |
| Stryker Corporation | $61.43 | 2022-2025 | Xpress Loprofile |
| Medtronic, INC. | $58.58 | 2024-2025 | Pteye Parathyroid Detection System, Propel |
| Endo USA, INC. | $57.75 | 2024-2025 | Xiaflex |
| Janssen Biotech, INC. | $43.85 | 2024-2025 | Tremfya |
| Merck Sharp & Dohme LLC | $23.73 | 2025 | Keytruda |
| Endo Pharmaceuticals INC. | $22.88 | 2024 | Xiaflex |
| Amgen INC. | $22.19 | 2025 | Tezspire |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17.10 | 2025 | Tula |
| Hikma Pharmaceuticals USA | $15.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dov Bloch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.